Clinical Trials Logo

Post-surgical Inflammation clinical trials

View clinical trials related to Post-surgical Inflammation.

Filter by:
  • None
  • Page 1

NCT ID: NCT03521791 Recruiting - Pterygium Clinical Trials

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.

PRO-155/IV
Start date: December 13, 2017
Phase: Phase 4
Study type: Interventional

Title of the study Efficacy and safety of PRO-155 (Zebesten ofteno®) on inflammation of the conjunctival surface in subjects with grade I-III pterygium vs placebo. Hypothesis H0. The Zebesten® ophthalmic solution (bromfenac 0.09%) is less effective and safe than placebo in reducing conjunctival hyperemia in subjects with grade I-III pterygium. H1 The Zebesten® ophthalmic solution (bromfenac 0.09%) is more effective and safe than placebo in reducing conjunctival hyperemia in subjects with grade I-III pterygium. Objective To evaluate the efficacy and safety of PRO-155 (bromfenac 009%) ophthalmic solution in the treatment of conjunctival hyperemia and ocular surface inflammation in a clinical model of pterygium grade I to III.

NCT ID: NCT00404937 Withdrawn - Clinical trials for Post-surgical Inflammation

Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation